After pushing back the decision date for Applied Therapeutics’ metabolic disorder drug govorestat, the FDA has now decided ...

The Food and Drug Administration (FDA) has cleared an investigational new drug application for the novel treatment, APTN-101, ...

Shares of Arrowhead Pharmaceuticals on Tuesday climbed in pre-market trading after the company said that it plans to file a new drug application with the U.S. Food and Drug Administration by the end ...

PharmaTher Holdings Ltd. (the “Company” or “PharmaTher”) (OTCQB: PHRRF) (CSE: PHRM), a specialty pharmaceutical company, today announced an update for its New Drug Application for Ketamine from the U.

The company announced an update on the ongoing New Drug Application (NDA) review of govorestat for Classic Galactosemia.

The German big pharma will submit a new drug application to the US FDA after success at phase 3 for nerandomilast.

Yale Child Study Center at the Yale School of Medicine in the USA, Hannover Medical School in Germany and Tel Aviv Sourasky Medical Center in ...

Applied Therapeutics shares jumped in premarket trading after the company said that its new drug application will proceed with a priority review with regulators without other delays. Shares traded ...

Patient and public health groups worry about a potential patent grant to Gilead Sciences for the HIV drug lenacapavir in ...

Developing advanced drug screening tools is crucial for the advancement of personalized medicine and the creation of more ...

Nuvation Bio Inc. (NYSE: NUVB), a late clinical-stage, global biopharmaceutical company tackling some of the greatest unmet needs in oncology, today a ...

The Fox News Health Newsletter brings you trending and important stories about health warnings, drug shortages, mental health ...